FdaApplication
ANDA 212876
Identifiers
- fda_app_no: ANDA212876
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2024-06-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE | EQ 450MG BASE | TABLET;ORAL |
1 product